Bacterial vaginosis (BV) is a vaginal dysbiosis in which the usual Lactobacillus-dominant environment is replaced by a more diverse anaerobic bacterial pattern. It commonly presents with thin white or gray discharge, a fishy odor, and a vaginal pH above 4.5, although some people have few symptoms. Recurrence after standard treatment is common, especially when the vaginal ecosystem does not return to a stable Lactobacillus-rich state.

Ayurveda understands conditions affecting the yoni under yoni vyapad, disorders of the female reproductive channel. The Charaka Samhita describes twenty forms of yoni vyapad and classifies them through doshic patterns rather than through modern microbial categories. A BV-like presentation is most often approached through a kapha-dominant lens when discharge is pale, sticky, slimy, heavy, or itchy, with pitta involvement when burning, heat, redness, or yellowish discharge is present. This framework does not replace laboratory diagnosis; it helps an Ayurvedic practitioner individualize supportive care after the condition has been properly assessed.

Dosha-Based Root Cause Identification

The Ayurvedic approach begins with careful observation of discharge quality, odor, itching, burning, tissue sensitivity, menstrual timing, bowel habits, diet, stress, sexual exposures, antibiotic history, and use of scented or intravaginal hygiene products. These details guide whether the main therapeutic emphasis should be reducing kapha and kleda, cooling pitta, stabilizing apana vata, or rebuilding tissue resilience after depletion.

Kapha-predominant pattern: White, pale, grayish, sticky, slimy, or heavy discharge with itching, mild discomfort, dampness, and little burning. Classical descriptions of kaphaja yoni vyapad include sliminess, coldness, itching, mild pain, and pale or slimy discharge. Supportive care emphasizes lighter meals, reduced added sugar and refined carbohydrates, less heavy dairy where it increases mucus or heaviness, improved daily movement, gentle external hygiene, and practitioner-selected bitter, astringent, and kapha-reducing herbs.

Pitta-predominant pattern: Burning, heat, redness, tenderness, stronger odor, yellowish discharge, irritability, loose stools, or symptom flares around hotter phases of the cycle. Classical pittaja descriptions include burning, inflammation, heat, and discolored discharge. Because yellow, green, painful, or foul-smelling discharge can also indicate sexually transmitted infections or pelvic infection, this pattern should be medically evaluated rather than self-treated. Ayurvedic support focuses on cooling, non-irritating care and avoidance of excessive heat, alcohol, very spicy food, and harsh topical applications.

Vata-predominant or vata-involved pattern: Dryness, thin or scanty discharge, irritation after antibiotics, stress-related recurrence, post-menstrual dryness, perimenopausal dryness, irregular bowel habits, or pelvic sensitivity. Classical teaching gives vata a central role in yoni disorders, especially through apana vata. Supportive care emphasizes regular meals, sleep rhythm, bowel regularity, stress reduction, mucosal nourishment, and avoidance of repeated drying or astringent applications that aggravate irritation.

The Triphala External Wash Protocol

Triphala is the classical combination of Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellirica), and Amalaki (Emblica officinalis). In Ayurvedic gynecological care, decoctions and washes are described among local therapies, and Triphala appears in classical formulations used for yoni disorders. In a modern home-care setting, this should be interpreted conservatively as an external vulvar rinse only, not internal douching. Internal douching can disturb the protective vaginal flora and should be avoided.

Preparation: Add 1 teaspoon of good-quality triphala powder to 500 ml of water. Bring to a gentle boil, simmer for 10 minutes, and allow it to cool completely to room temperature. Strain through a very fine clean cloth so that no powder particles remain. Prepare fresh each time and discard any leftover liquid.

Application: After bathing, pour a small amount externally over the vulvar area or use clean cotton to gently rinse the external folds only. Do not insert a syringe, nozzle, finger, cloth, or applicator inside the vagina. Pat dry with a clean towel and allow the area to remain dry and breathable. Use once daily for up to 3-5 days for external comfort when approved by a qualified practitioner, then stop. Discontinue immediately if burning, dryness, rash, pain, or worsening odor occurs. Avoid this wash during pregnancy unless your obstetrician or qualified clinician has approved it.

Internal Ayurvedic Support for Rebuilding the Terrain

Internal Ayurvedic care for recurrent BV is not meant to sterilize the vagina. The goal is to support digestion, reduce ama and kleda, regulate apana vata, and strengthen the mucosal terrain so that a healthy vaginal environment can re-establish itself after proper medical treatment. Herbs should be chosen by a qualified Ayurvedic practitioner, especially during pregnancy, breastfeeding, fertility treatment, chronic illness, liver disease, autoimmune disease, or when taking prescription medicines.

Shatavari (Asparagus racemosus) is traditionally used as a nourishing reproductive tonic and is most appropriate when dryness, tissue sensitivity, depletion, or vata-pitta irritation accompanies recurrent discharge. It appears in classical reproductive formulations and is better suited to rebuilding and moistening patterns than to heavy, sticky kapha states unless balanced with other herbs.

Guduchi (Tinospora cordifolia) is used in Ayurveda as a rasayana and as a support for metabolic and immune steadiness. In recurrent BV care, it may be selected when the pattern includes pitta-kapha disturbance, poor resilience, inflammatory tendency, or recurrence after repeated illness or antibiotic use. Classical yoni formulations include guduchi in combination with other herbs, and it should be dosed according to constitution and clinical context.

Neem or Nimba (Azadirachta indica) is bitter, cleansing, and traditionally associated with itching, microbial overgrowth patterns, skin disorders, and kapha-pitta conditions. It is not a daily reproductive tonic and should not be self-prescribed for long periods. It is generally avoided during pregnancy and while trying to conceive unless specifically directed by a qualified clinician.

Dietary Protocol for Yoni Flora Rebalancing

The vaginal microbiome does not exist in isolation from the rest of the body. Ayurveda views recurrent discharge through digestion, tissue quality, kleda, ama, and apana vata, while modern vaginal microbiome science recognizes BV as a shift away from a Lactobacillus-dominant environment. Diet cannot replace treatment for BV, but it can support the terrain in which recurrence either settles or repeats.

Increase: warm, freshly prepared meals; vegetables; adequate protein; legumes and whole grains in digestible portions; clean water; seasonal fruits; and food-level fermented preparations if tolerated, such as plain unsweetened yogurt, takra, kanji, or kefir. Amla and pomegranate may be used as food-level sour-astringent supports when they suit the person’s digestion. Fermented foods are taken by mouth only; no food, yogurt, oil, herb paste, or probiotic capsule should be inserted into the vagina unless specifically prescribed in a clinical setting.

Reduce: added sugar, sweetened drinks, refined flour, frequent fried or heavy foods, alcohol, and excess dairy when it increases heaviness, mucus, or dampness. A lower-glycemic, fiber-rich pattern is especially useful for kapha-dominant recurrence. Regular bowel movements, adequate sleep, daily walking, breathable cotton underwear, and avoiding tight damp clothing are simple but important parts of yoni care.

Important Safety Notes and When to See a Doctor

Bacterial vaginosis requires proper diagnosis because its symptoms overlap with yeast infection, trichomoniasis, chlamydia, gonorrhea, cervicitis, urinary infection, and other conditions that need different treatment. Seek prompt medical care if you are pregnant, have pelvic pain, abdominal pain, fever, bleeding, sores, severe burning, green or frothy discharge, a partner with a sexually transmitted infection, symptoms after a new sexual exposure, or symptoms that recur after treatment. Symptomatic BV during pregnancy should be managed with conventional obstetric care because untreated BV is associated with adverse pregnancy outcomes.

Avoid internal douching, vaginal steaming, scented washes, deodorants, perfumed pads, and unverified intravaginal remedies. Ayurvedic care can be a useful supportive framework for recurrence, diet, tissue resilience, and constitution, but it should not replace indicated antibiotics or medical evaluation. Work with a qualified Ayurvedic practitioner and a licensed healthcare provider when symptoms are persistent, recurrent, or occurring during pregnancy.

Medical Disclaimer: This content is for educational purposes only and does not replace medical diagnosis or treatment. Bacterial vaginosis and other vaginal infections require diagnosis by a qualified healthcare provider. Do not substitute herbal protocols for conventional treatment of confirmed infections, especially during pregnancy. Always consult your healthcare provider before beginning any herbal treatment for vaginal conditions.

References

1. CDC
2. NCBI
3. Frontiersin (frontiersin.org)
4. Frontiersin (frontiersin.org)
5. Charaka Samhita — Yonivyapat Chikitsa
6. Choprafoundation (choprafoundation.org)
7. Exploring of Antimicrobial Activity of Triphala Mashi-an Ayurvedic Formulation (2008), PubMed Central
8. Ayurvedic Pharmacopoeia of India
9. Ayurvedic Pharmacopoeia of India
10. Tinospora cordifolia: One plant, many roles (2012), PubMed Central
11. The Antimicrobial Potential of the Neem Tree Azadirachta indica (2022), PubMed Central
12. Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment (2016), PubMed Central
13. Sciencedirect (sciencedirect.com)
14. Nature (nature.com)

A parent contacted me after several months of their four-year-old child skipping bowel movements for three to four days at a stretch. When the stool finally came, it was hard, large, and painful enough that the child began to hold back. Each painful episode made the next one more frightening, and the fear of going to the bathroom became part of the constipation itself. The pediatrician had recommended polyethylene glycol, which helped move the stool but sometimes produced loose, urgent bowel movements that the child found distressing in a different way. The parents wanted a gentler long-term approach alongside appropriate medical care.

Ayurveda is well suited to supportive care in this situation because its pediatric approach begins with food, warmth, lubrication, routine, and non-forceful external measures before stronger interventions are considered. In Kaumarabhritya, the Ayurvedic branch concerned with child health, bowel function is treated as a daily sign of digestive balance. For a child who is withholding because stool has become painful, the goal is not simply to “make the child go.” The goal is to make the stool soft, comfortable, and predictable so the child’s body and mind can trust the bathroom again.

How Ayurveda Reads This Pattern

In Ayurvedic language, constipation is closely related to disturbed Apana Vata, the downward-moving aspect of Vata involved in elimination. When dryness, fear, irregular meals, low fluid intake, too much dry food, or repeated painful stooling disturb this downward movement, the stool can become hard, delayed, and difficult to pass. The classical corrective direction is therefore simple: restore warmth, moisture, oiliness, regular timing, and calm downward movement.

This is why the Ayurvedic pediatric constipation approach centers on warm cooked food, adequate fluids, small amounts of unctuous foods when tolerated, regular toilet rhythm, and gentle abdominal massage. Herbs come later, and in children they should be selected conservatively. Adult laxative habits are not appropriate for children, and even mild herbs should be adjusted to age, constitution, appetite, stool pattern, and medical history.

Understanding the Child’s Digestive Pattern: Koshtha Types

Classical Ayurveda classifies bowel tendency as Koshtha, the inherent ease or difficulty with which the bowel moves. This helps explain why two children eating similar food may have very different stool patterns. One child may become loose easily, while another becomes dry and delayed unless meals, fluids, and routine are carefully maintained.

Mridu Koshtha means a soft or easy bowel tendency. These children may pass stool easily and may be more prone to loose stool during illness, heat, or excessive laxative foods. They need the gentlest intervention and can be overcorrected quickly.

Madhyama Koshtha means a moderate bowel tendency. These children usually pass stool with reasonable regularity when food, sleep, activity, and hydration are steady. They often respond well to routine and food correction.

Krura Koshtha means a hard or difficult bowel tendency. These are the children who most easily develop dry, delayed, painful stool, especially with irregular eating, insufficient fluids, excess dry snacks, emotional stress, or fear after a painful bowel movement. They usually need consistency rather than occasional strong purging.

The treatment approach should match the child’s Koshtha. A child with Mridu Koshtha may only need a few days of warm food, fluids, and routine. A child with Krura Koshtha often needs a steady plan: softening foods daily, reduced binding foods, a calm toilet rhythm, and practitioner-guided support if food measures are not enough.

Age-Appropriate Food Interventions

Food is the first and safest layer of care for most children with functional constipation. Introduce one change at a time, keep the child well hydrated, and observe whether stool becomes softer and easier without causing urgency, cramping, or loose motion.

Soaked raisins or soft dried fruit: For children who can chew safely, soak a small handful of raisins overnight in water and give the softened raisins with the soaking water in the morning. For younger children, the soaked fruit should be mashed or chopped to reduce choking risk. Raisins, prunes, and similar dried fruits contain fiber and naturally occurring sorbitol, which can help retain water in the bowel and soften stool. Honey should never be added for children under 12 months.

Ghee with warm food or milk when tolerated: Ayurveda uses the principle of Snehana, or lubrication, for dryness-dominant patterns. A small amount of plain ghee mixed into warm porridge, soft rice, soup, or warm milk may support a softer stool in a dry, hard-bowel child. Milk is not ideal for every child; if dairy worsens constipation, causes mucus, bloating, or discomfort, use warm food instead or avoid it.

Figs, prunes, pears, and stewed apple: Older children who can chew well may benefit from soaked figs, soaked prunes, ripe pears, or stewed apple. Dried fruits should be soaked until soft, and they should be paired with water rather than given as a dry snack. This keeps the intervention moist and gentle rather than rough and dehydrating.

Warm cooked fiber instead of dry roughage: Children with hard, delayed stool often do better when fiber is warm, moist, and cooked. Choose vegetable soups, soft dals, warm porridges, stewed fruit, well-cooked greens, and cooked vegetables with a little healthy fat. Increase fiber gradually and always pair it with fluids. Too much dry cereal, refined flour, processed snacks, excessive dairy, and large amounts of white rice can make stool harder in some children.

Gentle Herbal Interventions by Age Group

In children, herbs should not be treated like casual home laxatives. The safest sequence is food, fluids, bathroom routine, and massage first. Herbal support can be helpful, but it should be age-appropriate and guided by a qualified Ayurvedic practitioner or healthcare provider, especially when constipation is recurrent, painful, or associated with withholding.

Belly Massage: The Underused Pediatric Tool

Gentle abdominal massage fits the Ayurvedic principle of external Snehana: warmth, touch, oil, and calm support for a Vata-aggravated pattern. It is especially useful when the child has begun to fear the bathroom, because it gives the body a non-threatening signal of softness and relaxation rather than pressure and urgency.

Technique: Warm one to two teaspoons of sesame oil, coconut oil, or another tolerated food-grade oil to body temperature and test it on the skin first. With the child lying down comfortably, use the palm of one hand to make slow clockwise circles around the navel. Keep the pressure gentle, never painful. Continue for three to seven minutes, ideally in the morning before breakfast or at bedtime. Avoid massage immediately after meals, during fever, vomiting, severe abdominal pain, marked bloating, skin irritation, or whenever the child resists.

Bathroom Routine That Breaks the Holding Cycle

A constipated child needs predictability more than pressure. Ask the child to sit on the toilet for five to ten relaxed minutes after breakfast or dinner, when the body’s natural bowel reflex is stronger. Use a footstool so the knees are supported and slightly raised. Praise sitting, breathing, and trying; do not punish, shame, or force stool to come. The purpose is to make the bathroom safe again.

For a four-year-old, the emotional tone matters as much as the food. A child who expects pain will clench the pelvic floor and hold back. Warm meals, a soft belly massage, a calm post-meal toilet sit, and reassurance from the parent can gradually replace fear with routine.

A Simple Four-Week Plan for a Four-Year-Old

This plan is appropriate only when there are no red-flag symptoms and the child is otherwise well. It can be used as supportive care while staying in touch with the child’s pediatrician, especially if a laxative has already been prescribed.

Week 1: Begin a daily warm breakfast, increase fluids through the day, offer soaked raisins or another soft soaked fruit if the child can chew safely, and start a calm toilet sit after breakfast. Keep the language light: “We are helping the poop become soft,” not “You have to go.”

Week 2: Add a small amount of ghee into warm food if tolerated. Reduce excessive dairy, refined snacks, dry packaged foods, and large portions of binding foods while the stool is hard. Keep fruit moist and cooked or soaked rather than relying only on raw roughage.

Week 3: Add gentle clockwise belly massage most days. Keep the bathroom routine consistent and reward cooperation, not stool production. The child should feel successful for sitting calmly, breathing, and listening to the body.

Week 4: If the child is still passing hard stool only every three to four days, still crying or withholding, or needing repeated rescue laxatives, schedule a review with the pediatrician and a qualified Ayurvedic practitioner. The next step should be individualized rather than simply increasing home remedies.

When to Escalate to a Pediatrician

Ayurvedic support is appropriate for functional constipation, but medical evaluation is necessary when warning signs are present. Seek prompt medical care for blood in the stool, constipation starting from birth or the first month of life, delayed passage of meconium as a newborn, repeated vomiting, green or bilious vomiting, severe abdominal distention, fever, significant abdominal pain, weight loss, poor growth, abnormal weakness or neurological signs, abnormal anal appearance, or constipation that does not improve despite consistent care.

Chronic constipation can also coexist with other conditions that need specific evaluation. If the child has poor growth, persistent abdominal symptoms, unusual fatigue, or repeated constipation despite a careful plan, the pediatrician may consider causes such as celiac disease, thyroid dysfunction, anatomical problems, or other medical factors.

Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner or healthcare provider before starting any new health regimen for a child, and do not stop or change prescribed treatment without medical guidance.

References

1. Naspghan (naspghan.org)
2. Healthychildren (healthychildren.org)
3. Cks (cks.nice.org.uk)
4. Ncismindia (ncismindia.org)
5. Charaka Samhita — Koshtha
6. Charaka Samhita — Dosha
7. Charaka Samhita — Grahani Chikitsa
8. Charaka Samhita — Snehana %28unction therapy%29
9. Webprod (webprod.hc-sc.gc.ca)
10. Dailymed (dailymed.nlm.nih.gov)
11. NCCIH
12. NCCIH
13. CDC
14. Bbuk (bbuk.org.uk)
15. Hopkinsmedicine (hopkinsmedicine.org)
16. Mayoclinic (mayoclinic.org)
17. Chop (chop.edu)
18. NHS
19. Caringforkids (caringforkids.cps.ca)
20. Analysis of the efficacy of abdominal massage on functional constipation: A meta-analysis (2023), PubMed Central
21. Vinmec (vinmec.com)
22. NCBI

When Yoshinori Ohsumi received the 2016 Nobel Prize in Physiology or Medicine for discoveries on the mechanisms of autophagy, a cellular recycling process became widely discussed outside cell biology. Autophagy is the cell’s regulated system for enclosing selected intracellular material in autophagosomes and delivering it to lysosomes, where the contents are degraded and reused.

Ayurveda approaches bodily maintenance through a different language: agni, ama, langhana, upavasa, shodhana, and rasayana. These terms should not be treated as literal equivalents of autophagy. Ama is an Ayurvedic concept linked with impaired digestion and metabolic residue, while autophagy is a measurable cellular pathway. Still, both frameworks give importance to periodic clearing, metabolic discipline, and renewal.

This article reviews the most relevant bridges between Ayurvedic herbs, Ayurvedic fasting logic, and modern autophagy biology. The practical conclusion is cautious: some herbal constituents show meaningful activity in cellular models, fasting has the strongest mechanistic fit, and no herb should be presented as a guaranteed human autophagy activator at ordinary household doses.

Autophagy 101: The Molecular Machinery

Autophagy is regulated by nutrient sensing, cellular stress, lysosomal activity, and autophagic flux. A single marker is rarely enough to prove that cellular cleanup is complete; LC3-II may indicate autophagosome formation, while p62/SQSTM1 trends and flux assays help clarify whether cargo is actually being degraded.

Curcumin (Haridra): The Clearest Herbal Signal

Haridra, the rhizome of Curcuma longa, is one of the most discussed Ayurvedic botanicals in modern molecular pharmacology. In Ayurvedic practice it is commonly used in kapha-pitta, skin, wound-support, and metabolic contexts; in modern laboratory work, its principal yellow constituent curcumin has one of the stronger preclinical autophagy profiles among Ayurveda-associated compounds.

Curcumin has been reported to increase LC3-II formation and autophagic flux in human colon cancer cell models while acting through the TFEB-lysosome pathway. In a cellular Parkinson’s disease model involving A53T alpha-synuclein, curcumin was associated with recovery of macroautophagy through downregulation of mTOR/p70S6K signaling. These findings make curcumin a legitimate autophagy candidate in mechanistic discussion, especially for gut and cellular stress contexts.

The major limitation is delivery. Curcumin is poorly water soluble, rapidly metabolized, and generally produces low plasma levels after ordinary oral intake. Enhanced formulations and combination with piperine can increase measured bioavailability, but the presence of a stronger pharmacokinetic profile does not automatically mean that a culinary dose of turmeric produces a clinically meaningful autophagy effect throughout the body.

Triphala: Digestive Rasayana, Polyphenols, and a More Cautious Autophagy Link

Triphala is the classical three-fruit combination of Amalaki (Phyllanthus emblica), Bibhitaki (Terminalia bellirica), and Haritaki (Terminalia chebula). Ayurveda uses it widely as a digestive, bowel-regulating, and rasayana formulation, and modern analyses describe it as rich in phenolic compounds such as gallic acid, chebulinic acid, chebulagic acid, and related tannins.

The strongest responsible link between Triphala and autophagy is indirect: Triphala belongs to the Ayurvedic digestive-cleaning and rasayana tradition, while some of its constituent phenolics are plausible modulators of oxidative stress, AMPK-related signaling, and cellular stress adaptation. Finished Triphala should therefore be framed as a digestion-centered polyphenol formula with possible relevance to cellular housekeeping, not as an established autophagy drug.

This distinction matters because Triphala is often taken daily and is generally discussed in Ayurveda through agni, mala regulation, bowel rhythm, and rasayana support. Translating that whole-practice use into a single molecular claim would oversimplify the formulation. Its most practical place in this review is as a traditional digestive rasayana whose chemistry makes autophagy-related investigation reasonable.

Resveratrol and Draksha (Vitis vinifera)

Draksha refers to grape or raisin from Vitis vinifera. In Ayurvedic usage it is generally understood as nourishing, sweet, and cooling rather than pungent or scraping. Its relevance to autophagy comes mainly through resveratrol, a stilbene found in grapes, especially in skins, and studied widely in nutrient-sensing and stress-response pathways.

Resveratrol has been associated with AMPK, SIRT1, and autophagy signaling in cellular models, including models of neurodegenerative stress. In Parkinson’s disease cell models, resveratrol promoted autophagy-related degradation of alpha-synuclein in a manner linked with AMPK and SIRT1 signaling.

The practical caution is dose and form. Draksha as a food or Ayurvedic dietary substance is not equivalent to a high-dose resveratrol supplement, and resveratrol itself has low oral bioavailability because of rapid metabolism. Draksha can remain a valuable Ayurvedic food-herb in its own right, but its autophagy relevance should be discussed through the narrower lens of resveratrol pharmacology.

Withaferin A and Ashwagandha: Proteostasis Rather Than Simple Clean-Up

Ashwagandha (Withania somnifera) is classically valued as a rasayana and balya herb. Its steroidal lactones, especially withanolides such as withaferin A, have been explored in cellular stress, inflammation, cancer biology, and proteostasis models.

Withaferin A should not be presented as a simple universal autophagy activator. In breast cancer cell lines, it has been associated with autophagosome formation, unfolded protein response, and disruption of autophagy flux. This places withaferin A in the category of context-dependent proteostasis modulation rather than everyday “cellular cleanup” support.

For Ayurvedic interpretation, this distinction is important. Ashwagandha’s traditional use as a strengthening rasayana is broader than withaferin A pharmacology. The herb, the whole extract, and the isolated constituent should not be treated as interchangeable, and cancer-cell stress findings should not be generalized to routine wellness use.

Piperine, Pippali, and Maricha: Bioavailability First

Piperine is an alkaloid associated with black pepper (Piper nigrum, Maricha) and long pepper (Piper longum, Pippali). In Ayurveda, pungent digestive spices are often used to support agni and formulation performance; in modern pharmacology, piperine is best known for altering absorption and metabolism of co-administered compounds.

Direct autophagy-related findings exist for piperine in selected experimental models, including a rotenone-induced Parkinson’s disease model and prostate cancer cell lines. These findings are mechanistically interesting, but they are not the strongest practical reason piperine appears in this discussion.

The stronger bridge is bioavailability. Piperine has been shown to increase curcumin bioavailability in a human pharmacokinetic study, which supports the traditional habit of combining warming digestive spices with heavier or less absorbable botanicals. This same property also creates safety concerns because piperine can alter drug handling; it should be used cautiously with prescription medicines, anticoagulants, antidiabetic drugs, anticonvulsants, and other narrow-therapeutic-index medications.

Langhana and Upavasa: The Practice With the Strongest Mechanistic Fit

Among all Ayurveda-related interventions discussed here, langhana and upavasa have the clearest conceptual fit with autophagy. Charaka Samhita, Sutra Sthana 22, describes langhana as lightening therapy and includes upavasa among its methods. This places fasting and digestive restraint inside a larger clinical logic, not as a one-size-fits-all wellness trend.

Modern autophagy biology also places nutrient withdrawal near the center of autophagy activation. When nutrient and growth signals fall, mTOR activity can decrease and autophagy-permissive pathways can become more active. This does not mean every person should fast aggressively; Ayurvedic langhana is traditionally selected according to strength, dosha, disease state, season, age, and digestive capacity.

For practical use, short digestive rest, lighter meals, and clinician-guided fasting are more consistent with Ayurvedic reasoning than extreme fasting performed without assessment. People with diabetes, pregnancy, eating disorders, frailty, active infection, serious chronic illness, or medication schedules that require food should avoid unsupervised fasting.

Evidence Assessment Summary

The most balanced view is that Ayurveda offers a lifestyle and formulation context that overlaps with modern cellular housekeeping biology, while the strongest herb-specific claims remain preclinical. Fasting and metabolic rhythm have the most direct mechanistic alignment; individual herbs and isolated compounds are better described as candidates with context-specific molecular actions.

What This Means Practically

The most useful takeaway is not “take this herb to switch on autophagy.” A better Ayurvedic interpretation is that cellular housekeeping is supported by digestive clarity, appropriate lightening when indicated, good meal rhythm, suitable herbs, and avoidance of chronic overload.

1. Langhana and upavasa provide the strongest bridge because nutrient sensing is central to autophagy regulation.
2. Curcumin and resveratrol have meaningful cellular autophagy signals, but dose, tissue exposure, metabolism, and formulation matter.
3. Triphala is best understood as a classical digestive rasayana with polyphenol chemistry, not as a proven autophagy-specific supplement.
4. Piperine’s main relevance is bioavailability enhancement, which is useful but also creates interaction risks.
5. Withaferin A findings belong mainly to cellular stress and cancer-model biology, not routine rejuvenation claims.
6. More autophagy is not automatically better; autophagy is a regulated process that varies by tissue, disease state, age, and metabolic context.

For a practical Ayurvedic routine, the safest starting point is usually regular meals, avoidance of constant snacking, lighter dinners when appropriate, seasonal digestive support, and practitioner-guided herb selection. Strong fasting protocols, concentrated extracts, and piperine-enhanced formulas should be treated as interventions rather than casual wellness habits.

Future Research Directions

The most useful next step is to evaluate traditional Ayurvedic interventions with biomarkers that distinguish autophagosome formation from completed autophagic flux. Whole formulations and practice patterns deserve attention, because Ayurveda rarely uses isolated molecules in isolation from diet, timing, constitution, and digestive status.

• Human studies measuring autophagy-related markers before and after properly characterized Ayurvedic formulations.
• Studies comparing whole Triphala, turmeric preparations, and isolated constituents rather than assuming equivalence.
• Pharmacokinetic work measuring tissue exposure, not only plasma levels, for curcumin, resveratrol, piperine, and withanolides.
• Clinical studies that pair langhana-style dietary timing with safety screening and individualized Ayurvedic assessment.
• Protocols that include p62, LC3, lysosomal markers, and flux-sensitive interpretation instead of relying on one marker.

The intersection of autophagy and Ayurveda is promising when handled with precision. Ayurveda contributes a long-standing clinical language of lightening, digestion, cleansing, and renewal; molecular biology contributes tools for measuring cellular degradation and recycling. The bridge is strongest when neither system is forced to say more than it actually says.

References

1. NobelPrize.org
2. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks (2012), PubMed Central
3. Monitoring and Measuring Autophagy (2017), PubMed Central
4. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy (2008), PubMed Central
5. Curcumin targets the TFEB-lysosome pathway for induction of autophagy (2016), PubMed Central
6. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy (2013), PubMed
7. Improving Curcumin Bioavailability: Current Strategies and Future Perspectives (2021), PubMed Central
8. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice (2014), PubMed Central
9. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
10. Insights into the potential benefits of triphala polyphenols toward the promotion of resilience against stress-induced depression and cognitive impairment (2023), PubMed Central
11. Ayurvedic Pharmacopoeia of India
12. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease (2011), PubMed
13. Resveratrol: A Double-Edged Sword in Health Benefits (2018), PubMed Central
14. Withaferin A: From Ancient Remedy to Potential Drug Candidate (2021), PubMed Central
15. Withaferin A induced impaired autophagy and unfolded protein response in human breast cancer cell-lines MCF-7 and MDA-MB-231 (2017), PubMed
16. Oncotarget (oncotarget.com)
17. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy (2013), PubMed
18. Bioenhancers: Revolutionary concept to market (2010), PubMed Central
19. Charaka Samhita — Langhanabrimhaniya Adhyaya
20. System-wide Benefits of Intermeal Fasting by Autophagy (2017), PubMed Central
21. NCCIH

Sluggish gut movement can appear as early fullness, post-meal heaviness, bloating, nausea, delayed stomach emptying, functional dyspepsia, chronic constipation, or difficult evacuation. Modern gastroenterology describes motility as the coordinated movement of smooth muscle under the influence of the enteric nervous system, interstitial cells of Cajal, hormones, and local reflexes. Functional dyspepsia and functional constipation are common worldwide, but their prevalence varies by diagnostic criteria, so they are better described separately rather than as one fixed global percentage.

Conventional prokinetic medicines can be useful in selected patients, but they require medical supervision. Metoclopramide carries a boxed warning for tardive dyskinesia, domperidone is associated with serious cardiac risks, and erythromycin may lose sustained prokinetic value with repeated use because of tachyphylaxis. This has kept interest alive in carefully chosen digestive herbs, especially those traditionally described in Ayurveda as Deepana, Pachana, and Anulomana.

The Motility System: Ayurveda and Modern Physiology

Ayurveda does not describe the gut through the same anatomical language as modern physiology, but it gives a practical framework for digestion, appetite, assimilation, and elimination. Agni refers to digestive capacity; Samana Vayu supports digestion and movement around the stomach and small intestine; Apana Vayu governs downward movement and elimination; and Annavaha and Purishavaha srotas describe the functional channels of food intake and fecal movement.

Modern motility depends on coordinated activity across the stomach, small intestine, and colon. A prokinetic agent may increase coordinated contractions, improve gastric emptying, support antral movement, or help bowel transit, but different herbs act in different regions and should not be treated as interchangeable.

Herb 1: Ginger (Zingiber officinale) – Best-Supported for Upper-GI Movement

Ginger is one of the most useful Ayurvedic digestive herbs for upper-GI sluggishness. The Ayurvedic Pharmacopoeia of India identifies dried ginger rhizome as Shunthi and describes it as Katu in rasa, Laghu and Snigdha in guna, Ushna in virya, and Madhura in vipaka, with Anulomana, Deepana, Pachana, Hrdya, and Vata-Kapha-pacifying actions. Its pungent constituents include gingerols and shogaols.

Human data on ginger are strongest for gastric emptying and antral movement. In healthy volunteers, 1.2 g ginger powder accelerated gastric emptying and stimulated antral contractions. In functional dyspepsia, ginger stimulated gastric emptying and antral contractions, while symptom benefit was not uniform in that trial. A separate randomized trial used a standardized combination of ginger extract and artichoke leaf extract in functional dyspepsia and reported improvement in dyspeptic symptoms, so that result is best understood as a combination-formula finding rather than ginger-alone proof.

Practical use: The pharmacopoeial dose for Shunthi powder is 1-2 g. In household practice, ginger may be used as a small fresh slice before meals, as tea, or in food when there is heaviness, weak appetite, or Kapha-Vata type digestive sluggishness. People with active gastritis, strong burning, bleeding risk, gallbladder disease, pregnancy, or anticoagulant use should seek professional guidance before using concentrated ginger preparations. For kitchen preparation ideas, see Ginger 8 Ways: Healing Recipes.

Herb 2: Triphala – Classical Bowel Regulation Across the Lower GI Tract

Triphala is the classical three-fruit combination of Haritaki, Bibhitaki, and Amalaki. It is best understood as a bowel-regulating and rasayana formulation rather than a single-target prokinetic drug. Its lower-GI relevance comes mainly from Haritaki’s Anulomana action, the tannin-rich fruit chemistry of the three ingredients, and its long use in constipation-prone patterns where bowel regularity, stool form, and downward movement are the goals.

Human clinical literature on Triphala and constipation is smaller and less standardized than the literature on ginger and gastric emptying. Older clinical use and open-label formula data support its role as a bowel regulator, while plain Triphala should not be represented as a proven replacement for stimulant laxatives or prescription prokinetics. In practice, Triphala is often selected when constipation is chronic, mild to moderate, and linked with irregular diet, dryness, or sluggish elimination.

Practical use: Triphala Churna is commonly taken at bedtime with warm water when the therapeutic aim is morning bowel regularity. The exact amount should be individualized by constitution, stool type, strength of digestion, age, pregnancy status, and concurrent medication use. For broader context, see How Triphala Reshapes Your Gut.

Herb 3: Haritaki (Terminalia chebula) – The Anulomana Anchor

Haritaki is the most important single Triphala fruit for downward movement. The Ayurvedic Pharmacopoeia of India describes Haritaki as the pericarp of mature Terminalia chebula fruit and lists all rasas except Lavana: Kashaya, Katu, Tikta, Amla, and Madhura. Its guna are Laghu and Ruksha, its virya is Ushna, its vipaka is Madhura, and its actions include Anulomana, Deepana, Rasayana, Hrdya, Medhya, and Sarvadosha-prashamana.

Classically, Haritaki is used in conditions such as Vibandha and Udavarta, both of which relate to impaired downward movement and constipation-type obstruction. Preclinical work with Terminalia chebula preparations also supports an effect on intestinal transit and morphine-induced constipation models, making Haritaki the clearer motility-related component within Triphala.

Practical use: Haritaki is stronger and more directional than many general digestive herbs. It may be chosen when constipation, difficult evacuation, bloating from retained stool, or Vata-type obstruction predominates. Because it can alter bowel movement and may not suit loose stools, dehydration, pregnancy, frailty, or active inflammatory bowel conditions, it should be used with practitioner guidance.

Herb 4: Pippali (Piper longum) – Digestive Adjunct, Not a Stand-Alone Prokinetic

Pippali is a valued Deepana and Rasayana herb, but it should not be presented as a proven stand-alone gastric-emptying accelerator. The Ayurvedic Pharmacopoeia of India describes Pippali as the dried immature fruit of Piper longum, with Madhura, Katu, and Tikta rasa; Laghu and Snigdha guna; Anushna virya; Madhura vipaka; and actions including Deepana, Rucya, Vatahara, Kaphahara, Tridoshahara, Rasayana, and Recana.

Modern piperine literature is especially relevant for bioavailability and drug interaction potential. Piperine can modify absorption and metabolism of co-administered compounds, which explains why Pippali is often used in small quantities in formulations such as Trikatu. Animal data also indicate that isolated piperine can inhibit gastric emptying and gastrointestinal transit, so it is more accurate to place Pippali as a digestive stimulant and formulation adjunct rather than the primary prokinetic herb.

Practical use: Pippali may be useful in low appetite, Kapha-type heaviness, and formulations designed to kindle Agni. It should be used cautiously with prescription medicines, anticoagulants, antidiabetic drugs, antiepileptic drugs, narrow-therapeutic-index medicines, pregnancy, acidity, or inflammatory gut irritation.

Herb 5: Chitraka and Ajwain – Strong Deepana-Pachana Choices for Selected Patients

Chitraka and Ajwain are sharper digestive herbs that fit selected patterns of heaviness, gas, weak appetite, and cold sluggish digestion. They are not gentle daily tonics for everyone. Their value comes from classical Deepana-Pachana and carminative roles rather than from large human trials in gastroparesis or functional constipation.

Chitraka is identified in the Ayurvedic Pharmacopoeia of India as the root of Plumbago zeylanica and contains plumbagin. It is Katu in rasa, Laghu, Ruksha, and Tikshna in guna, Ushna in virya, Katu in vipaka, and has Deepana, Pachana, Grahi, Kaphavatahara, Shulahara, and related actions. The pharmacopoeia also specifies purification before use, making it unsuitable for casual self-treatment.

Ajwain, or Yavani, is identified as the dried fruit of Trachyspermum ammi. Its rasa are Katu and Tikta; its guna are Ruksha, Laghu, and Tikshna; its virya is Ushna; its vipaka is Katu; and its actions include Deepana, Pachana, Rucya, Anulomana, Shulahara, and Krimighna. It is especially appropriate as a culinary digestive aid when gas, abdominal discomfort, and heaviness follow meals.

Meal Spacing, Langhana, and the Migrating Motor Complex

The migrating motor complex is a fasting-state pattern of stomach and small-intestinal movement that is interrupted by eating. It recurs cyclically during the interdigestive period and helps move residual material and bacteria through the gut. Motilin is one of the key hormones involved in this fasting motility pattern.

Ayurveda’s caution against Adhyashana, eating again before the previous meal is digested, fits this practical principle: digestion works better when appetite, meal size, and spacing are respected. This does not require aggressive fasting. For many people, the most relevant step is simply avoiding constant grazing, eating only when the previous meal feels digested, and keeping meals lighter when Agni is weak.

A Practical Motility-Support Framework

A safe Ayurvedic motility plan should be pattern-based rather than herb-stacking. The aim is to support Agni, reduce post-meal stagnation, encourage downward movement, and avoid suppressing serious disease signs. The following framework is educational and should be individualized by a qualified practitioner.

• Before meals: Use a small amount of fresh ginger, ginger tea, or a ginger-lime appetizer only when there is low appetite, heaviness, or cold digestive sluggishness without burning.
• With meals: Prefer warm, freshly cooked, easy-to-digest food; avoid overeating and repeated snacking before the previous meal is digested.
• For gas and bloating: Use culinary Ajwain in small amounts when the pattern is cold, heavy, and gaseous, and avoid excess if there is acidity or burning.
• For constipation-prone patterns: Consider Triphala or Haritaki under guidance, especially when the aim is downward movement and bowel regularity.
• For stronger Agni-kindling: Formulations containing Pippali or Chitraka should be reserved for appropriate constitutions and supervised use.
• For monitoring: Persistent vomiting, severe abdominal distension, unexplained weight loss, blood in stool, black stool, dehydration, fever, severe pain, or suspected obstruction requires prompt medical assessment.

For understanding how carrier substances may influence herbal delivery and tolerability, see The Science of Anupana.

Safety and Scope

Digestive herbs can support appetite, comfort, gas relief, and bowel regularity, but gut motility disorders can also arise from diabetes, neurological disease, thyroid disease, intestinal obstruction, medication effects, infection, inflammatory bowel disease, or post-surgical complications. Do not replace prescribed prokinetic medicines or laxatives without medical advice. Consult a qualified Ayurvedic practitioner and healthcare provider before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, breastfeeding, elderly, managing a chronic condition, giving herbs to a child, or taking medication.

References

1. Global prevalence of functional dyspepsia according to Rome criteria, 1990-2020: a systematic review and meta-analysis (2024), PubMed Central
2. Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis (2021), PubMed
3. NIDDK
4. Frontiersin (frontiersin.org)
5. FDA
6. FDA
7. The migrating motor complex: control mechanisms and its role in health and disease (2012), PubMed
8. Small intestinal bacterial overgrowth: a comprehensive review (2007), PubMed Central
9. NCBI
10. Microflora modulation of motility (2011), PubMed Central
11. Prevalence of Adhyashana in patients attending IPGT and RA Hospital and its effect on health (2011), PubMed Central
12. Ayurvedic Pharmacopoeia of India
13. Europepmc (europepmc.org)
14. Effect of ginger on gastric motility and symptoms of functional dyspepsia (2011), PubMed Central
15. The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial (2015), PubMed Central
16. Ginger in gastrointestinal disorders: A systematic review of clinical trials (2019), PubMed Central
17. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
18. Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders (2018), PubMed Central
19. Ia800501 (ia800501.us.archive.org)
20. Spasmogenic Activity of the Seed of Terminalia chebula Retz in Rat Small Intestine: In Vivo and In Vitro Studies (2011), PubMed Central
21. Ayurvedic Pharmacopoeia of India
22. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials (2022), PubMed Central
23. Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice (2001), PubMed
24. Trachyspermum ammi (2012), PubMed Central
25. Ginger in gastrointestinal disorders: A systematic review of clinical trials (2019), PubMed
26. Strategies and outcomes for aortic endograft explantation (2019), PubMed
27. Does simulation-based training in medical education need additional stressors? An experimental study (2020), PubMed
28. A Web-based Game for Teaching Facial Expressions to Schizophrenic Patients (2017), PubMed
29. Gender differences in alcohol-induced neurotoxicity and brain damage (2013), PubMed
30. Electromembrane extraction as a rapid and selective miniaturized sample preparation technique for biological fluids (2015), PubMed
31. Opiate drug use in the city of Madrid: Associated health and sociodemographic factors (2021), PubMed

Triphala is one of Ayurveda’s most widely used polyherbal formulations. Its name simply means “three fruits,” and the formulation is built from Amalaki, Haritaki, and Bibhitaki. Classical Ayurveda does not present Triphala as a single-purpose drug. It places the formula within a broader logic of Rasayana, digestion, elimination, eye support, Kapha-Pitta balance, and bowel regulation, depending on dose, preparation, anupana, season, constitution, and the clinical context.

From a phytochemical point of view, Triphala is best understood as a tannin- and polyphenol-rich matrix rather than a single “active compound.” The three fruits contribute overlapping families of phenolic acids, hydrolysable tannins, ellagitannins, flavonoids, ascorbic acid, and related plant constituents. This layered chemistry fits the traditional formulation logic: the fruits are not chemically identical, but they share enough common ground to act as a coherent combination.

The Three Fruits: Classical Identity and Phytochemical Contributions

The common Triphala churna is generally prepared from Amalaki, Haritaki, and Bibhitaki in equal parts, although exact usage may vary by lineage, formulation, and therapeutic purpose. The Ayurvedic Pharmacopoeia of India identifies these drugs by botanical source, organ used, classical properties, and quality parameters, while modern analytical work uses marker compounds such as gallic acid, ellagic acid, chebulagic acid, and chebulinic acid to evaluate the formulation.

Tannins and Polyphenols: The Dominant Chemical Logic

The most consistent chemical theme in Triphala is its richness in tannins and related phenolic compounds. These constituents help explain the formula’s astringent taste, its affinity for the gut, and its use in contexts where digestion, mucosal tone, elimination, and Rasayana support are central. In chemistry, the important point is not that Triphala contains one miraculous molecule, but that it delivers many related compounds in a naturally buffered plant matrix.

Gallic Acid: The Common Thread

Gallic acid is one of the most useful chemical markers for understanding Triphala because it appears across the three fruits and is readily measured in quality-control methods. It is chemically active as a phenolic compound, but it should not be treated as the whole explanation for Triphala. In the formulation, gallic acid exists alongside ellagic acid, chebulagic acid, chebulinic acid, corilagin, flavonoids, tannins, and fruit fiber, creating a wider matrix than any isolated supplement can provide.

The Amalaki Vitamin C Question

Amalaki is accurately associated with ascorbic acid, and the Ayurvedic Pharmacopoeia of India lists ascorbic acid and tannins among its constituents. In Triphala, however, Amalaki should not be reduced to vitamin C alone. Its contribution is a sour-astringent, cooling, Rasayana fruit matrix containing ascorbic acid together with tannins and other polyphenols. This is why Triphala’s antioxidant and rejuvenative identity is better understood through the whole fruit combination rather than through a vitamin-C-only explanation.

Ellagic Acid, Urolithins, and the Gut-Microbiome Bridge

Triphala’s chemistry becomes especially meaningful in the digestive tract. Its tannins and polyphenols contact intestinal microbes, and ellagic acid-related compounds can be transformed by gut microbiota into urolithin metabolites. Urolithin A is a microflora-derived metabolite studied for mitochondrial and mitophagy-related effects, which gives a modern biochemical vocabulary for one part of Triphala’s gut-centered Rasayana logic.

This does not mean every person converts Triphala polyphenols in the same way. Microbial metabolism varies from person to person, and the final effect depends on the raw material, preparation, dose, bowel pattern, diet, and the individual’s digestive capacity. In Ayurvedic terms, this keeps the focus on agni, prakriti, anupana, and clinical suitability rather than on a one-size-fits-all molecule.

What a Practical Dose of Triphala Delivers

The exact milligram amount of each compound in a serving of Triphala varies by fruit quality, harvest, storage, powder fineness, extraction method, and manufacturer. A fixed chemical table for every 5 g dose can therefore be misleading. A more reliable way to understand a practical serving is to describe the classes of material it delivers.

Synergy: Why the Classical Combination Still Matters

The strongest way to describe Triphala’s synergy is through complementarity. Haritaki contributes Anulomana, Dipana, Medhya, and Rasayana qualities; Bibhitaki contributes Kapha-Pitta balancing, Kashaya, Kasahara, and Bhedaka qualities; Amalaki contributes Shita, Rasayana, Chakshushya, and Tridoshajit qualities. Chemically, all three fruits show antioxidant and polyphenol activity, but their profiles are not identical. The formulation combines shared phenolic chemistry with distinct classical actions.

This is precisely the logic of an Ayurvedic yoga: the combination is not merely three powders mixed together, but a balanced formulation in which the fruits temper and complete one another. Haritaki’s bowel-moving and digestive orientation, Bibhitaki’s Kapha-facing astringency, and Amalaki’s cooling Rasayana nature together create a broader profile than any one fruit alone.

Practical Implications for Patients and Practitioners

Understanding Triphala’s chemistry helps practitioners choose and use it more intelligently. Product quality matters because the same label can hide large differences in fruit identity, storage, processing, and marker content. Airtight storage away from heat, humidity, and strong light helps protect polyphenol-rich powders. Warm water is a common anupana for churna when the goal is bowel regulation and digestion, while other vehicles may be chosen according to constitution and therapeutic purpose.

For routine wellness, traditional churna may be suitable when properly chosen and tolerated. For research, manufacturing, or clinical standardization, marker compounds such as gallic acid, ellagic acid, chebulagic acid, and chebulinic acid are useful. Neither approach replaces Ayurvedic assessment: dose, timing, anupana, bowel pattern, agni, prakriti, pregnancy status, medication use, and disease state all matter.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Triphala should be used under the guidance of a qualified Ayurvedic practitioner or healthcare provider, especially for therapeutic use, pregnancy or breastfeeding, chronic illness, loose stools, dehydration risk, diabetes medication, anticoagulant or antiplatelet medication, immunosuppressant medication, or drugs with narrow safety margins. Stop use and seek medical guidance if it causes persistent diarrhea, abdominal pain, allergy, weakness, or unusual symptoms.

References

1. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed
2. Ayurvedic Pharmacopoeia of India
3. Immunomodulatory effects of triphala and its individual constituents: a review (2014), PubMed Central
4. Rjpponline (rjpponline.org)
5. Rjpponline (rjpponline.org)
6. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents (2005), PubMed
7. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation (2018), PubMed
8. Link (link.springer.com)
9. Mdpi (mdpi.com)
10. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans (2019), PubMed
11. Cytochrome P450 inhibitory potential of Triphala–a Rasayana from Ayurveda (2011), PubMed
12. Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with phenacetin and midazolam in rats (2022), PubMed Central
13. Study of the safety of oral Triphala aqueous extract on healthy volunteers (2020), PubMed
14. Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review (2021), PubMed Central
15. Exploring scientific validation of Triphala Rasayana in ayurveda as a source of rejuvenation for contemporary healthcare: An update (2021), PubMed
16. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota (2020), PubMed
17. In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins (2015), PubMed

Clinical Virechana is a physician-directed Panchakarma procedure, not a home cleanse. In the classical model it is performed through three stages: purva karma (preparation), pradhana karma (the main purgation), and pashchat karma (post-procedure recovery). The classical clinical endpoint may be assessed as minimum, moderate, or maximum purification, with 10, 20, or 30 purgative urges respectively. That level of purgation requires individual assessment of strength, bowel habit, disease state, digestion, season, medicine, dose, vital signs, hydration, and post-procedure diet. It should be performed only under the direct supervision of a qualified Panchakarma physician in an appropriate clinical setting.

This article is about a conservative mridu virechana or mild anulomana-style approach: a gentle bowel-clearing plan for adults who have been cleared by a qualified Ayurvedic practitioner or healthcare provider. The aim is not to reproduce clinical Virechana at home, not to chase 10 or more purges, and not to treat stool color as proof of cleansing. The practical aim is mild downward movement, comfort, and careful recovery while avoiding dehydration, electrolyte disturbance, cramping, weakness, and over-purgation.

When Pitta Needs Clearing: Signs and Timing

Classical seasonal guidance places Pitta accumulation around the rainy season and Pitta aggravation in Sharad Ritu (autumn), when the body habituated to rain and coolness is suddenly exposed to stronger sun heat. Charaka’s seasonal regimen for autumn emphasizes sweet, light, cool, slightly bitter, Pitta-pacifying food and mentions purgation in this season when appropriate. For home care, this seasonal principle should be applied conservatively: diet, rest, and mild bowel support are preferable to aggressive self-purgation.

A Conservative Three-Day Home Protocol

This protocol is a mild educational framework for a generally healthy adult who has been advised that mild bowel support is suitable. It is not a substitute for clinical Panchakarma. Do not combine purgatives, do not repeat the process frequently, and do not continue if loose stools become forceful, watery, painful, or weakening.

Day 1: Preparation

The day before mild bowel clearing should be simple and digestive. Eat warm, freshly cooked, easy-to-digest food such as rice gruel, thin moong dal soup, soft khichdi, or well-cooked vegetables. Avoid heavy, fried, oily, stale, cold, raw, very spicy, very sour, and alcohol-containing foods. A small amount of ghee with food may be suitable for many Pitta patterns, but self-directed multi-day oleation is not advised. Keep the day quiet, avoid strenuous exercise, drink warm water as thirst allows, and sleep early.

Day 2: Mild Bowel-Clearing Day

Choose only one agent, and choose it according to practitioner advice, medical history, product quality, and label instructions. Classical Virechana is commonly administered late morning, around the time Kapha naturally decreases and Pitta rises, but common mild laxatives differ in onset; Triphala, for example, is slower and is not a same-morning clinical Virechana agent.

During the active period, stay at home and near a bathroom. Rest between urges. Sip warm water as needed, do not strain, and do not suppress the natural urge to pass stool. Do not eat a full meal until the purgative effect has settled and natural hunger returns. A comfortable mild response is enough; repeated watery stools, severe cramps, dizziness, faintness, vomiting, blood, confusion, or inability to pass urine are stop signs and require medical attention.

Day 3: Recovery

Post-procedure food is as important as the bowel-clearing day. Classical samsarjana krama rebuilds digestion gradually after purification by beginning with thin rice preparations and then moving toward thicker grains, green gram soup, and simple khichdi. For a mild home approach, keep the recovery simple and light.

1. First meal, when true hunger returns: thin rice gruel or rice water, warm, plain, and small in quantity.
2. Second meal: thicker rice gruel with a little rock salt or cumin if tolerated.
3. Third meal: thin moong dal soup with soft rice, or very soft khichdi.
4. Next day: return gradually to normal food if appetite, strength, and bowel movements are steady.

Avoid heavy, fried, raw, cold, stale, very spicy, very sour, and processed foods for at least the next two to three days. Avoid hard exercise, travel, alcohol, late nights, and excess sun exposure. For related digestive support, see How Triphala Reshapes Your Gut.

Castor Oil: The Traditional Favorite, With Caveats

Castor oil is derived from Ricinus communis and is recognized in modern medicine as a stimulant laxative for temporary relief of occasional constipation. Its main laxative activity is linked to ricinoleic acid, released by intestinal lipases, which activates prostanoid receptors in smooth muscle and promotes intestinal propulsion. Its onset is commonly within 1-3 hours, which is why it must be handled more cautiously than slower agents such as Triphala.

Key cautions for castor oil use:

• Do not use it in pregnancy, because castor oil can stimulate uterine smooth muscle and may induce labor.
• Do not combine it with other stimulant laxatives.
• Do not use it when there is abdominal pain of unknown cause, suspected obstruction, appendicitis, perforation, active inflammatory bowel disease, or severe dehydration.
• Older adults, people with kidney or heart problems, and anyone at risk of electrolyte imbalance need medical supervision.
• Stop and seek care if cramping, vomiting, bloating, dizziness, repeated watery stools, weakness, confusion, or faintness appears.

Who Should NOT Do Home Virechana

Even mild purgation is not suitable for everyone. Classical texts and modern safety guidance both place strong limits around purgative therapy. When in doubt, choose diet, rest, and practitioner consultation rather than self-administered purgation.

• Pregnant people: Home Virechana and castor oil are contraindicated.
• Children, older adults, weak, very thin, very obese, or debilitated people: Use only under qualified supervision.
• Active diarrhea, rectal bleeding, blood in urine, active vaginal bleeding, acute fever, acute rhinitis, or rectal injury: Do not purge.
• Inflammatory bowel disease, suspected intestinal blockage, appendicitis, bowel perforation, or severe abdominal pain: Do not use stimulant or purgative agents.
• Severe dehydration or known electrolyte imbalance: Correct this medically before any bowel-clearing intervention.
• Eating disorders or history of laxative misuse: Avoid purgation unless managed by appropriate healthcare professionals.
• People taking cardiac medications, diuretics, corticosteroids, licorice-containing products, or medicines affected by laxatives: Consult a healthcare provider before using laxative herbs or formulas.

Frequency and Long-Term Strategy

For seasonal Pitta management, the classical rhythm points toward autumn, especially after the rains, but frequency must be individualized. A healthy adult may only need seasonal diet correction, cooling routines, and occasional mild bowel support. Chronic acidity, recurrent inflammatory skin eruptions, bleeding tendencies, bowel disease, or repeated heat symptoms require a qualified practitioner’s plan rather than repeated self-cleansing.

Between any purgative interventions, support Pitta with the autumn principles: food and drink that are sweet, light, cool, and slightly bitter; meals taken only when appetite is clear; and avoidance of excess sun, heavy oils, curd, alkaline preparations, day sleep, and overheating. For related seasonal guidance, see our article on the Summer Heatstroke Prevention protocol. For understanding carrier substances in Ayurvedic preparations, review The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Home purgation carries risks, including dehydration, electrolyte imbalance, cramping, weakness, fainting, and worsening of underlying conditions. Always consult a qualified Ayurvedic practitioner and your healthcare provider before attempting Virechana, even in mild form. Seek immediate medical attention for prolonged watery stools, severe abdominal pain, repeated vomiting, blood in stool, dizziness, fainting, confusion, chest symptoms, or signs of dehydration. Full-strength clinical Virechana must never be attempted without professional supervision.

References

1. Charaka Samhita — Virechana
2. Charaka Samhita — Upakalpaniya Adhyaya
3. Charaka Samhita — Tasyashiteeya Adhyaya
4. Charaka Samhita — Pitta dosha
5. Webprod (webprod.hc-sc.gc.ca)
6. Dravyaguna notes
7. Ayurvedic Pharmacopoeia of India
8. NCBI
9. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors (2012), PubMed
10. Betterhealth (betterhealth.vic.gov.au)

Triphala is the classical three-fruit formulation made from haritaki, bibhitaki, and amalaki. Its best-known phytochemical profile is dominated by tannins and phenolic compounds such as gallic acid, ellagic acid, chebulinic acid, and chebulagic acid. Oleanolic acid belongs to a different chemical family: it is a hydrophobic pentacyclic triterpenoid found widely in medicinal plants and foods. In the context of Triphala, it is best understood as a minor, variable constituent and a useful pharmacological lens for discussing liver protection, bile-acid handling, glucose metabolism, and metabolic resilience.

This does not reduce Triphala to one isolated compound. Ayurveda explains Triphala through its combined actions on agni, anulomana, rasayana, dosha balance, and prameha-related metabolic states. Oleanolic acid simply adds one modern biochemical pathway by which some of Triphala’s liver- and metabolism-supportive themes can be understood alongside its better-established polyphenol chemistry.

What Can Be Said Reliably About Oleanolic Acid in Triphala?

The Ayurvedic Pharmacopoeia of India describes the three Triphala fruits by their botanical identity, classical properties, therapeutic uses, and major constituent groups, but it does not standardize Triphala by oleanolic acid content. For this reason, fixed claims such as exact milligrams of oleanolic acid per gram of Triphala should be avoided unless a specific batch has been analytically tested. A more accurate approach is to describe oleanolic acid as a plausible triterpenoid contributor within a broader formula whose main quality markers remain tannins, gallotannins, and other polyphenols.

Oleanolic acid is chemically distinct from these dominant phenolic markers. It is lipophilic, circulates differently from water-soluble tannins, and has been studied for effects on cytoprotective liver pathways, bile-acid signaling, carbohydrate digestion, insulin signaling, and pancreatic beta-cell function. That makes it relevant to Triphala’s modern interpretation, even though it should not be presented as the sole or guaranteed active principle of the formulation.

Hepatoprotective Pathways Associated With Oleanolic Acid

Oleanolic acid has been studied in liver models because it interacts with the body’s own stress-response and detoxification systems. These mechanisms are especially relevant when discussing Triphala’s traditional use as a rasayana and anulomana formulation, because proper elimination, metabolic steadiness, and tissue protection are central to the way Triphala is used in practice.

Nrf2 and Endogenous Antioxidant Defense

One of the most important liver-related pathways associated with oleanolic acid is Nrf2 signaling. Nrf2 is a transcription factor that helps regulate cytoprotective genes such as heme oxygenase-1, NAD(P)H quinone dehydrogenase 1, glutathione-related enzymes, and other antioxidant-defense systems. In acetaminophen-induced liver injury models, oleanolic acid has been described as supporting Nrf2 nuclear accumulation and increasing protective gene expression, with both Nrf2-dependent and additional protective processes involved.

This complements the polyphenol-rich nature of Triphala. Gallic acid, ellagic acid, chebulagic acid, chebulinic acid, and related tannins provide a strong antioxidant and tissue-protective background, while triterpenoid constituents such as oleanolic acid offer a different kind of support through endogenous cellular defense pathways.

Bile-Acid and Cholestasis Biology

Oleanolic acid also intersects with bile-acid regulation, including FXR and Nrf2-linked pathways in experimental cholestatic liver injury models. This is relevant because the liver does not only neutralize toxins; it also produces, transports, and recycles bile acids. Balanced bile flow is important for digestion, lipid handling, and hepatic comfort.

This pathway also requires caution. Concentrated or high-dose oleanolic acid behaves differently from the small, variable triterpenoid fraction present in a whole herbal formula. Liver-supportive interpretation should therefore remain dose-aware, especially in people with gallbladder disease, bile-duct obstruction, cholestasis, hepatitis, cirrhosis, or abnormal liver enzymes.

Fibrosis-Related Signaling

Chronic liver stress can involve activation of hepatic stellate cells and increased collagen deposition, with TGF-beta and Smad signaling playing central roles in fibrotic progression. Oleanolic-acid chemistry and related triterpenoid derivatives have been investigated in relation to these fibrotic pathways. For Triphala, this supports a cautious liver-protective discussion, but it should not be turned into a claim that ordinary Triphala dosing reverses fibrosis or cirrhosis.

Glucose-Metabolism Pathways Associated With Oleanolic Acid

Triphala is traditionally relevant to prameha, and oleanolic acid offers several modern pathways that fit a metabolism-supportive interpretation. These include slower carbohydrate breakdown in the intestine, improved insulin-signaling tone, beta-cell support, and reduced hepatic insulin resistance in experimental settings.

Slower Carbohydrate Breakdown in the Gut

Oleanolic acid inhibits alpha-glucosidase enzymes, which help break complex carbohydrates into absorbable glucose. By slowing this step, alpha-glucosidase inhibition can reduce the speed of post-meal glucose entry into the bloodstream. This is the same enzyme class targeted by drugs such as acarbose, though Triphala should not be treated as a substitute for prescribed diabetes medication.

Insulin Signaling and PTP1B

Protein tyrosine phosphatase 1B, or PTP1B, is a negative regulator of insulin signaling. Oleanolic acid has been identified as a natural PTP1B inhibitor, and this mechanism is relevant to insulin sensitivity because excessive PTP1B activity can dampen insulin-receptor signaling. Within Triphala, this mechanism fits the broader prameha-supportive theme, especially alongside haritaki and amalaki, both of which are listed in the Ayurvedic Pharmacopoeia of India for prameha.

Beta-Cell Function and Hepatic Insulin Resistance

Oleanolic acid has also been described in pancreatic beta-cell and islet models as supporting insulin secretion and protecting beta-cell function under metabolic stress. In liver-related metabolic models, it has been associated with improved hepatic insulin resistance through antioxidant, lipid-regulating, and inflammation-modulating pathways. These actions are pharmacologically interesting because they touch both sides of glucose balance: insulin availability and the liver’s handling of glucose and lipids.

How This Fits With Ayurvedic Understanding of Triphala

Ayurveda does not define Triphala by oleanolic acid. The formula is understood through the combined qualities of its three fruits: haritaki’s anulomana, dipana, rasayana, and prameha relevance; bibhitaki’s kaphapittajit and bhedaka actions; and amalaki’s shita virya, rasayana action, tridoshajit quality, and prameha relevance. Together, these properties make Triphala especially suited to patterns involving sluggish elimination, disturbed agni, kapha-pitta imbalance, and long-term rasayana support.

Seen through this lens, oleanolic acid does not replace the classical explanation. It adds a modern layer: a lipophilic triterpenoid pathway that may complement Triphala’s tannin-rich antioxidant profile, its digestive and eliminative actions, and its traditional relevance to prameha.

Anupana, Timing, and Practical Use

The Ayurvedic Pharmacopoeia of India lists powder doses of 3–6 g for the individual dried fruits, and Triphala products commonly vary by preparation, particle size, extract ratio, and manufacturer. Because the oleanolic acid content of a Triphala product is not normally declared, practical use should be guided by the whole formulation, the person’s constitution, bowel pattern, digestive strength, diagnosis, and current medications rather than by an assumed oleanolic-acid dose.

Warm water is a common anupana when Triphala is used for bowel regularity and gentle anulomana. Classical rasayana discussions also include Triphala with honey and ghee. Since oleanolic acid is hydrophobic, a lipid-containing anupana such as ghee provides a reasonable pharmacokinetic rationale for certain rasayana-style uses, while warm water remains appropriate when the main aim is mild cleansing and regular elimination. Honey and ghee should be used according to classical rules and practitioner guidance rather than casually mixed in arbitrary quantities.

When the goal is metabolic support, Triphala timing should be individualized. Some people are advised to take it at bedtime for bowel regulation; others may be guided differently when prameha, appetite, digestion, or blood-sugar medication timing is involved. People using insulin, sulfonylureas, GLP-1 medicines, SGLT2 inhibitors, metformin, anticoagulants, or hepatically metabolized medicines should seek professional guidance before adding Triphala therapeutically.

Synthetic Oleanolic-Acid Derivatives and the Safety Lesson

Pharmaceutical development around oleanolic-acid chemistry led to synthetic triterpenoids such as bardoxolone methyl, also known as CDDO-Me. Bardoxolone methyl is a synthetic triterpenoid derived from oleanolic acid and has been developed for strong Nrf2-related activity. In a phase 3 trial involving patients with type 2 diabetes and stage 4 chronic kidney disease, bardoxolone methyl was stopped because of increased cardiovascular adverse events.

This history is useful but should be interpreted carefully. It does not mean Triphala behaves like bardoxolone methyl, and it does not mean natural oleanolic acid at dietary or herbal exposure levels has the same risk profile. It does show that stronger pathway activation is not automatically safer. Ayurveda’s emphasis on whole formulations, appropriate dose, suitable anupana, patient selection, and practitioner supervision remains important.

Bottom Line

Oleanolic acid is not the main classical marker of Triphala and should not be used to invent fixed potency claims for untested powders. Still, it is a meaningful compound for understanding why Triphala remains interesting in liver and glucose-metabolism discussions. Its links to Nrf2 signaling, bile-acid biology, alpha-glucosidase inhibition, PTP1B inhibition, beta-cell support, and hepatic insulin resistance fit well beside Triphala’s established polyphenol chemistry and its Ayurvedic roles in rasayana, anulomana, agni support, and prameha-oriented care.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Triphala and oleanolic acid mechanisms should not be used as substitutes for prescribed treatment for diabetes, hepatitis, fatty liver disease, cholestasis, cirrhosis, gallbladder disease, or any other medical condition. Consult a qualified Ayurvedic practitioner or healthcare provider before using Triphala therapeutically, especially if pregnant, breastfeeding, managing diabetes or liver disease, prone to diarrhea, or taking prescription medication.

References

1. Ayurvedic Pharmacopoeia of India
2. Triphala’s characteristics and potential therapeutic uses in modern health (2025), PubMed Central
3. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation (2018), PubMed
4. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases (2017), PubMed Central
5. Mdpi (mdpi.com)
6. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes (2009), PubMed
7. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes (2009), PubMed Central
8. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis (2022), PubMed
9. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice (2022), PubMed Central
10. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019 (2019), PubMed Central
11. Inhibition of alpha-glucosidase by oleanolic acid and its synthetic derivatives (2002), PubMed
12. Inhibitory mechanism of two allosteric inhibitors, oleanolic acid and ursolic acid on α-glucosidase (2018), PubMed
13. NCBI
14. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities (2008), PubMed
15. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades (2012), PubMed Central
16. Oleanolic acid enhances insulin secretion in pancreatic beta-cells (2008), PubMed
17. Protective effect of oleanolic acid against beta cell dysfunction and mitochondrial apoptosis: crucial role of ERK-NRF2 signaling pathway (2013), PubMed
18. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects (2013), PubMed
19. Potential Molecular Targets of Oleanolic Acid in Insulin Resistance and Underlying Oxidative Stress: A Systematic Review (2022), PubMed
20. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
21. Nrf2-dependent effects of CDDO-Me on bactericidal activity in macrophage infection models (2025), PubMed Central
22. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease (2013), PubMed
23. Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl (2014), PubMed

Triphala is the “three fruits” formulation of Haritaki (Terminalia chebula), Bibhitaki or Vibhitaki (Terminalia bellirica/Terminalia bellerica), and Amalaki (Emblica officinalis/Phyllanthus emblica), commonly prepared in equal parts as churna, decoction, or medicated ghee. In Ayurvedic eye care, its most defensible classical position is not merely as a digestive herb that incidentally benefits the eyes, but as an internal rasayana and a component of selected local netra-kriyakalpa practices when prepared and used appropriately.

Why Triphala Is Considered Chakshushya

In Ayurvedic language, chakshushya refers to substances and practices traditionally valued for the eyes and vision. Triphala fits this category because it combines cleansing, rasayana, and pitta-kapha balancing uses with a long-standing place in formulations for timira and netraroga. The National List of Essential AYUSH Medicines lists Triphala Ghrita with indications including Timira and Netraroga, and classical ophthalmic chapters include Triphala Ghrita in the management of eye disease.

This does not mean Triphala is a stand-alone cure for glaucoma, cataract, diabetic retinopathy, or retinal disease. It means Ayurveda places it within a wider eye-care framework that includes diet, bowel regulation, rasayana, medicated ghee, local procedures, seasonal discipline, and physician-guided treatment according to dosha, tissue involvement, disease stage, strength, age, and digestive capacity.

Mechanisms Relevant to Eye Health

Modern work on Triphala does not justify replacing ophthalmic treatment, but it does help explain why the formulation has remained important in Ayurvedic eye care. Its three fruits contain tannins and phenolic compounds such as gallic acid, ellagic acid, chebulagic acid, and chebulinic acid, which are relevant to oxidative stress, inflammatory signaling, tissue remodeling, and microvascular changes in ocular tissues.

Antioxidant and Lens Support

The retina is highly vulnerable to oxidative stress because of its oxygen demand, light exposure, and lipid-rich structure. Oxidative stress is also involved in cataract formation, diabetic retinal injury, glaucoma-related optic nerve damage, and age-related retinal degeneration. Triphala’s phenolic-rich profile supports its classical use as a protective rasayana for tissues exposed to oxidative load.

In experimental selenite-induced cataract models, Triphala protected lenses by improving antioxidant status and reducing lipid peroxidation. This supports the classical lens-support rationale, but it should not be interpreted as proof that Triphala can reverse human cataract or replace cataract surgery when surgery is indicated.

Retinal Pigment Epithelium and Fibrotic Remodeling

Retinal pigment epithelial cells are important for retinal integrity, and their abnormal migration and fibrotic transformation contribute to conditions such as proliferative vitreoretinopathy. In a human retinal pigment epithelial cell model, Triphala extracts and the Triphala constituents chebulagic acid and chebulinic acid reduced TGF-beta-induced epithelial-to-mesenchymal transition markers, cell migration, proliferation, and SMAD-3 phosphorylation.

This mechanism is relevant to retinal tissue remodeling, but it is not the same as proving an intraocular pressure-lowering effect in glaucoma. Claims that Triphala or gallic acid has been proven to reverse trabecular meshwork fibrosis in glaucoma should be treated cautiously unless supported by direct ophthalmic clinical evidence.

Retinal Microvascular Inflammation

Retinal microvascular inflammation is important in diabetic retinopathy and neovascular retinal disease. In retinal capillary endothelial cell models, Triphala-related compounds including chebulagic acid, chebulinic acid, and gallic acid inhibited TNF-alpha-induced pro-inflammatory and pro-angiogenic responses, including changes linked with endothelial migration, tube formation, and inflammatory mediators.

This provides a plausible adjunctive rationale for considering Triphala in broader metabolic and vascular eye-care plans, especially where pitta, rakta, kapha, and metabolic dysregulation are involved. It does not replace retinal screening, diabetic control, laser treatment, anti-VEGF injections, or other ophthalmologist-directed care.

Glaucoma and Optic-Nerve Care

Glaucoma is a progressive optic-nerve disease in which intraocular pressure, aqueous humour drainage, optic-nerve vulnerability, and vascular factors may all be relevant. Standard glaucoma care aims to lower intraocular pressure through prescription drops, laser, surgery, or other ophthalmic interventions. Triphala may be considered only as a supportive Ayurvedic measure under professional supervision, not as a substitute for glaucoma medicines.

For a person already diagnosed with glaucoma or ocular hypertension, the most important eye-saving actions are regular intraocular pressure checks, optic-nerve evaluation, visual-field monitoring, and adherence to prescribed treatment. Ayurvedic support may focus on rasayana, bowel regularity, inflammation reduction, sleep, diet, and safe physician-guided preparations, but prescription drops should never be stopped without the treating ophthalmologist’s agreement.

Classical Forms for Eye Care

Ayurvedic ophthalmology distinguishes internal formulations from local procedures. Triphala churna, Triphala decoction, and Triphala Ghrita are not interchangeable, and home preparation is not the same as a sterile clinical ophthalmic product. The eye is delicate; particles, contamination, wrong concentration, or improper handling can irritate the ocular surface and increase risk.

Triphala Jala or Triphala Kwatha for External Cleansing

Triphala water or decoction is traditionally used for external cleansing around the eyes and in physician-guided ophthalmic practice. A cautious household approach is to use freshly prepared, well-filtered Triphala water only for external cleansing around closed eyelids, not as a homemade drop placed into the open eye. Any preparation that is cloudy, gritty, fermented, old, or insufficiently filtered should be discarded.

A traditional-style preparation may involve soaking or gently decocting Triphala powder in clean water, allowing sediment to settle, and filtering repeatedly through a very fine sterile filter or cloth. Even then, household Triphala water should not be treated as a sterile eye drop. Burning, pain, increased redness, discharge, light sensitivity, blurred vision, or foreign-body sensation after use should be treated as a reason to stop and seek eye care.

Triphala Ghritam for Internal Use

Triphala Ghritam is a classical medicated ghee preparation in which Triphala is processed into ghee for internal rasayana use. The National List of Essential AYUSH Medicines lists Triphala Ghrita with indications including Timira and Netraroga, and gives an adult dose range of 10–15 g. In practice, dose and timing should be individualized by an Ayurvedic practitioner according to digestive strength, bowel tendency, metabolic status, age, and the nature of the eye condition.

Internal Triphala Ghritam is especially aligned with the Ayurvedic idea that the eyes require unctuous nourishment, pitta regulation, and rasayana support. It is not appropriate for everyone in the same dose. People with weak digestion, active nausea, loose stools, marked kapha accumulation, gallbladder or lipid-metabolism concerns, or those on complex medical treatment should use it only with qualified guidance.

Netra Tarpana

Netra Tarpana is a clinical Ayurvedic procedure in which medicated ghee is retained over the closed or gently opened eyes within a ring-like boundary for a defined period. Triphala Ghrita and other ghrita preparations may be selected according to the condition, dosha pattern, and practitioner assessment. This is not a home eye-bath; it requires clinical hygiene, correct medicine selection, correct duration, and post-procedure care.

Netra Tarpana is commonly considered for dry eye, ocular fatigue, vata-pitta irritation, and selected chronic ocular-surface complaints after proper examination. In an open-label comparative clinical trial on Shushkakshipaka correlated with dry eye syndrome, Triphala Ghrita Tarpana and Goghrita Manda Tarpana were used in a short supervised course and produced improvement in dry-eye symptoms and signs. This supports clinical use in dry-eye contexts, but it does not establish Netra Tarpana as treatment for all retinal, corneal, glaucomatous, or cataract conditions.

Dosage and Application Guide

The following guide is educational and conservative. Eye disease should be diagnosed first, and any internal or local Ayurvedic treatment should be matched to the patient rather than copied from a generic protocol.

Practical Ayurvedic Use Cases

For eye strain and dryness, Triphala is most appropriately considered as part of a broader plan that includes sleep correction, screen breaks, bowel regularity, adequate hydration, suitable fats, pitta-calming diet, and physician-guided ghrita where indicated. External Triphala preparations should be kept conservative and hygienic, while Netra Tarpana should be reserved for trained clinical settings.

For cataract tendency, Triphala’s classical and experimental rationale is antioxidant and rasayana support, not cataract reversal. A person with cloudy vision, glare, halos, or reduced night driving ability should have cataract assessment and follow the ophthalmologist’s advice on timing of surgery. Triphala Ghritam may be used as supportive Ayurveda when digestion, constitution, and medical status permit.

For diabetic retinopathy risk, Triphala may be considered only as an adjunct in a plan centered on blood-glucose control, blood-pressure control, lipid management, regular dilated retinal examinations, and timely retinal treatment. Its relevance is strongest as systemic rasayana and inflammatory-metabolic support, not as a replacement for diabetic eye care.

For glaucoma, Triphala should be framed even more cautiously. Glaucoma can progress silently and cause irreversible vision loss. Ayurvedic care may support the patient’s constitution and tissue resilience, but intraocular pressure and optic-nerve status must be monitored medically, and prescribed drops or procedures should continue unless the ophthalmologist changes them.

For related evidence-based herbal reviews, see our comprehensive guide on Triphala’s full pharmacological profile, our discussion of Nasyakarma for eye and neurological conditions, and Manjistha for vascular and eye support.

Safety and When to Seek Care

Glaucoma, cataract, diabetic retinopathy, retinal disease, corneal ulcer, eye injury, and sudden visual symptoms require assessment by a qualified ophthalmologist or healthcare provider. Ayurvedic treatments described here are adjunctive and should be used with guidance from a qualified Ayurvedic practitioner, especially when the preparation is internal ghrita or any local eye procedure. Never discontinue glaucoma drops, diabetic eye treatment, steroid drops, antibiotics, or other prescribed eye medicines without medical approval. Sudden vision loss, eye pain, halos around lights, severe redness, pus-like discharge, light sensitivity, new floaters, flashes, curtain-like shadow, or trauma to the eye requires urgent ophthalmological evaluation.

References

1. Journals (journals.plos.org)
2. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation (2018), PubMed
3. Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies (2010), PubMed
4. Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review (2022), PubMed Central
5. Upayushsociety (upayushsociety.com)
6. Easyayurveda (easyayurveda.com)
7. Efficacy of Triphala Ghrita and Goghrita Manda Tarpana in the management of Shushkakshipaka w.s.r. to dry eye syndrome: An open labelled randomized comparative clinical trial (2020), PubMed
8. NCBI
9. Mayoclinic (mayoclinic.org)
10. My (my.clevelandclinic.org)
11. Iovs (iovs.arvojournals.org)
12. Sciencedirect (sciencedirect.com)
13. Sciencedirect (sciencedirect.com)
14. Sciencedirect (sciencedirect.com)
15. LWW Journals

From an Ayurvedic perspective, this topic belongs under the broader idea of Rasayana: support for tissue strength, recovery, vitality, and healthy ageing. The herbs reviewed below should be understood as supportive Rasayana choices that may help the body handle oxidative and inflammatory stress. They do not block cosmic radiation, reduce a recorded millisievert dose, or replace dosimetry, shielding, distance, scheduling controls, or occupational medical supervision.

The Mechanisms of Radiation Injury

Ionising radiation can affect living tissue by directly ionising DNA and other cellular targets, and indirectly by splitting water molecules and generating reactive oxygen species. The resulting injury may involve DNA strand damage, lipid peroxidation, mitochondrial stress, apoptosis, inflammatory signalling, and suppression of rapidly dividing tissues such as bone marrow. A practical Ayurvedic radioprotective approach therefore emphasises Rasayana herbs that support antioxidant capacity, tissue repair, balanced inflammation, digestive strength, and overall resilience, while keeping modern radiation-safety measures as the first line of protection.

Herb 1: Ashwagandha (Withania somnifera)

Ashwagandha is one of Ayurveda’s best-known Rasayana and Balya herbs. The Ayurvedic Pharmacopoeia of India identifies the medicinal part as the dried mature root of Withania somnifera. For radiation-related support, Ashwagandha is most relevant because its root extract and withanolide constituents have been studied for redox balance, inflammatory modulation, and tissue protection in experimental gamma-radiation models. Animal work has reported protection of liver and spleen redox status after gamma irradiation, with changes in markers such as malondialdehyde, glutathione, and reactive oxygen species.

Practical use: A commonly used adult range is 2–3 g root powder daily, or 300–600 mg/day of a standardised root extract, adjusted to constitution, strength of digestion, sleep pattern, thyroid status, and concurrent medicines. For frequent flyers or aircrew, Ashwagandha is better used as a supervised Rasayana tonic rather than as a “radiation shield.” It is generally taken with warm milk, warm water, or ghee-based preparations when appropriate for the person’s constitution.

Herb 2: Triphala

Triphala combines Amalaki, Haritaki, and Bibhitaki, and is traditionally used as a Rasayana as well as a gentle bowel-regulating formulation. Its relevance to radiation stress comes from its polyphenol-rich profile and experimental gamma-radiation work in mice, where Triphala extract was associated with better survival patterns, reduced radiation sickness features, and protection against oxidative DNA and tissue damage. These findings align well with the Ayurvedic view of Triphala as a broad tissue-supporting and metabolic-balancing formulation.

The three fruits offer complementary Ayurvedic actions. Amalaki is cooling, nourishing, and Rasayana; Haritaki is valued for Vata regulation and elimination; Bibhitaki supports Kapha balance and tissue cleansing. Together, they are especially useful when the goal is not stimulation, but steady support for digestion, elimination, antioxidant reserve, and recovery from cumulative stress.

Practical use: A typical adult range is 1–3 g at bedtime, or 1–3 g twice daily when prescribed. Sensitive individuals should begin at the lower end because Triphala can loosen stools. People taking medicines metabolised through CYP3A4 or CYP2D6 pathways, people with diarrhoea, dehydration, pregnancy, or active cancer treatment should use it only with professional guidance.

Herb 3: Mandukparni / Gotu Kola (Centella asiatica)

Mandukparni, commonly identified with Centella asiatica, is described in Ayurvedic practice as a Medhya Rasayana, meaning a rejuvenative herb that supports mental clarity, nervous-system steadiness, and tissue repair. The Ayurvedic Pharmacopoeia of India recognises Mandukaparni as the dried whole plant of Centella asiatica. In radiation-related experimental work, Centella asiatica extract has been associated with protection of DNA and cell membranes from gamma-radiation injury, reduction of lipid peroxidation, and improved survival parameters in animal models.

Practical use: A common adult range is 250–500 mg of a standardised extract once or twice daily, or traditional whole-plant preparations as advised by an Ayurvedic practitioner. Mandukparni is most suitable when the person also needs support for mental fatigue, wound repair, stress sensitivity, or nervous-system recovery. It should be used cautiously in liver disease, with sedatives, with medicines metabolised through liver enzymes, and during pregnancy unless specifically advised.

Amalaki as a Standalone Radioprotective Rasayana

Amalaki (Emblica officinalis / Phyllanthus emblica) deserves separate mention because it is both a component of Triphala and a major standalone Rasayana. Experimental gamma-radiation work has described protective effects on the haematopoietic system and antioxidant enzymes in mice. In Ayurveda, Amalaki is valued for cooling, nourishing, Pitta-balancing, and rejuvenative qualities, making it especially appropriate when radiation-related support is combined with heat, dryness, eye strain, travel fatigue, or inflammatory tendency.

Practical use: Food-level use of amla, amla juice, or 1–3 g powder daily is a gentle starting point for many adults. Higher-dose antioxidant supplementation should be discussed with an oncologist during radiotherapy or chemotherapy, because protecting normal tissues without protecting tumour cells requires careful clinical judgement.

Full Radioprotective Support Protocol

The following table is a practitioner-discussion framework rather than a universal prescription. The best choice depends on constitution, digestion, sleep, bowel pattern, liver health, thyroid status, pregnancy status, occupational exposure pattern, and current medicines.

Practical Implementation for Frequent Flyers

For people flying occasionally, a separate radioprotective herb protocol is usually unnecessary. For pilots, cabin crew, radiology professionals, radiotherapy staff, and travellers with very high long-haul flight hours, the Ayurvedic focus should be steady Rasayana support, stable digestion, adequate sleep recovery, bowel regularity, hydration, and avoidance of excess alcohol around travel. The measurable radiation dose during flight is governed mainly by altitude, route, latitude, duration, and solar conditions, not by choosing a particular passenger seat.

For occupational exposure, the primary protection remains dose monitoring, route and schedule awareness where applicable, pregnancy-specific occupational policies, shielding, distance, and ALARA principles in clinical radiation settings. Herbs can support the person; they cannot replace exposure controls. People undergoing radiotherapy should not add high-dose antioxidant herbs or supplements without oncology approval.

For related science, our article on Ayurveda for pilots and flight crew covers the wider occupational picture, including jet lag and circadian disruption. The Rasayana therapy longevity review explains the broader Ayurvedic foundation behind rejuvenative support.

Safety and Clinical Guidance

Radiation exposure concerns should be discussed with an occupational health physician, aviation medical examiner, radiation safety officer, or treating oncologist as appropriate. The herbs described here are supportive botanicals, not medical devices, radiation shields, or substitutes for dosimetry, shielding, distance, route planning, or workplace radiation-safety protocols.

Consult a qualified Ayurvedic practitioner or healthcare provider before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant or breastfeeding, managing thyroid disease, liver disease, autoimmune disease, cancer, a bleeding disorder, chronic illness, or taking prescription medication. Ashwagandha, Triphala, Centella, and high-dose antioxidant products may not be appropriate for every person.

References

1. Airline pilot cosmic radiation and circadian disruption exposure assessment from logbooks and company records (2011), PubMed Central
2. Iaea (iaea.org)
3. Arpansa (arpansa.gov.au)
4. Arpansa (arpansa.gov.au)
5. NCBI
6. NCBI
7. Nrc (nrc.gov)
8. Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers (2014), PubMed Central
9. Ssgcbams (ssgcbams.co.in)
10. SAGE Journals
11. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells (2016), PubMed
12. Triphala, an ayurvedic rasayana drug, protects mice against radiation-induced lethality by free-radical scavenging (2004), PubMed
13. Protection against radiation oxidative damage in mice by Triphala (2006), PubMed
14. Ayurvedic Drug Triphala in Combination with Providone Iodine Mitigates Radiation-Induced Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response (2023), PubMed Central
15. Ayurvedic Pharmacopoeia of India
16. Protection of DNA and membranes from gamma-radiation induced damages by Centella asiatica (2009), PubMed
17. Europepmc (europepmc.org)
18. Modulation of haematopoetic system and antioxidant enzymes by Emblica officinalis gaertn and its protective role against gamma-radiation induced damages in mice (2004), PubMed
19. Mskcc (mskcc.org)
20. NCCIH
21. NCBI
22. NCBI
23. Oncolink (oncolink.org)

Within this background, Ayurvedic Chakshushya and Rasayana dravyas deserve careful, proportionate attention. The strongest human AMD data among botanicals discussed here belong to saffron, while Triphala, Yashtimadhu, and Netra Tarpana are better understood as classical and mechanistic adjuncts that may support ocular tissues, inflammation balance, and long-term eye nourishment under professional care.

Ayurvedic Theory of Eye Disease: Drishti and Alochaka Pitta

Classical Ayurveda does not name age-related macular degeneration as a modern retinal diagnosis, but disorders of vision are discussed under Drishtigata Rogas, including Timira and related states of progressive visual dimness. Alochaka Pitta is described as the Pitta subtype associated with the eyes and visual perception, while the Drishti is the visual apparatus through which sight is apprehended. In Ayurvedic interpretation, chronic retinal degeneration is approached through disturbance of Alochaka Pitta, age-related Vata aggravation, depletion of ocular nourishment, and gradual impairment of the channels and tissues supporting vision.

The classical aim is not to replace retinal examination or modern AMD treatment, but to preserve visual function through Vata-Pitta pacification, Chakshushya dravyas, Rasayana support, suitable ghrita-based therapies, and disciplined eye care. Timira descriptions in the classical ophthalmic sections emphasise progressive blurring, dimness, and altered perception; these are best used as Ayurvedic clinical frameworks rather than one-to-one disease labels for AMD.

Herb 1: Saffron (Crocus sativus) — The Retinal Function Support Herb

Kumkuma or saffron is listed in the Ayurvedic Pharmacopoeia of India as the dried stigma and style of Crocus sativus. Its recorded Ayurvedic profile includes Katu and Tikta rasa, Snigdha guna, Ushna virya, Katu vipaka, and actions that include Vatahara, Varnya, Vishaghna, Shleshmahara, Rasayana, and use in Drishti Roga. Its important constituents include crocin, picrocrocin, and volatile aromatic compounds, which also make saffron one of the more biologically plausible ocular botanicals for retinal support.

Saffron has the clearest human AMD signal in this group. A randomized crossover clinical trial in early AMD used 20 mg daily saffron for three months and reported improved focal electroretinogram flicker sensitivity, suggesting measurable macular function change. Follow-up work continued this 20 mg daily model, and other AMD trials have used 20–30 mg daily saffron supplementation with visual function outcomes such as mfERG, BCVA, and contrast-related measures. The practical clinical message is conservative: saffron is not an AMD cure, but it is the most substantiated botanical adjunct discussed here.

Practical range: clinical AMD trials commonly used 20 mg daily saffron, with some work using 30 mg daily. The Ayurvedic Pharmacopoeia lists 25–50 mg as the dose for Kumkuma. This should not be converted into gram-level daily saffron dosing. Use only good-quality saffron or a properly standardised product, and avoid high-dose saffron, especially in pregnancy or when medically vulnerable.

Herb 2: Triphala — Classical Chakshushya and Rasayana Support

Triphala combines Haritaki, Bibhitaki, and Amalaki, and is widely used in Ayurveda as a Rasayana and supportive formulation for digestion, elimination, and tissue balance. In eye care, Triphala is traditionally used internally and in ghrita-based preparations, including Triphala Ghrita, because the formulation is considered supportive for Netra Rogas when selected appropriately by a practitioner.

The retinal relevance of Triphala is best framed through its phytochemical and pre-clinical profile rather than as a proven stand-alone AMD treatment. Gallic acid, chebulagic acid, chebulinic acid, tannins, and related polyphenols are important Triphala-associated compounds. Experimental retinal endothelial work with Triphala-derived compounds has described modulation of inflammatory and pro-angiogenic pathways, and broader angiogenesis work has connected Triphala and chebulinic acid with VEGF-related signalling. This makes Triphala a reasonable Chakshushya-Rasayana adjunct in an Ayurvedic plan focused on long-term retinal nourishment, bowel regularity, and inflammation balance, but not a substitute for AREDS2 guidance, anti-VEGF treatment, or geographic atrophy care when indicated.

Practical use: Triphala dosing and form should be individualised. Churna, tablets, decoction-style preparations, and ghrita-based approaches are not interchangeable. In older AMD patients, strong laxative use can be inappropriate; the goal is gentle support, not aggressive purgation. Patients with frailty, dehydration risk, bowel disease, or multiple medications should use Triphala only under qualified guidance.

Herb 3: Yashtimadhu (Glycyrrhiza glabra) — Chakshushya Support with Safety Boundaries

Yashtimadhu, also known as licorice root, is listed in the Ayurvedic Pharmacopoeia of India as the dried root and stolon of Glycyrrhiza glabra. Its classical profile is Madhura rasa, Guru and Snigdha guna, Shita virya, Madhura vipaka, and actions including Chakshushya, Vata-Pitta-jit, Raktaprasadana, Shothahara, and Rasayana. This supports its inclusion in classical eye-health discussions, particularly where Pitta irritation, dryness, and tissue depletion are part of the Ayurvedic assessment.

The modern ocular interest in licorice is mainly pre-clinical. Isoliquiritigenin, a licorice-derived compound, has been evaluated in experimental ocular angiogenesis models, including choroidal and retinal neovascularisation models. This gives Yashtimadhu a plausible place as a supportive Chakshushya dravya, especially in a Vata-Pitta framework, but oral Yashtimadhu should not be presented as an anti-VEGF replacement or as a proven AMD therapy.

Safety boundary: non-deglycyrrhizinated licorice can raise blood pressure, lower potassium, promote fluid retention, and interact with medicines such as diuretics, antihypertensives, corticosteroids, and digoxin. Long-term Yashtimadhu use is inappropriate without medical supervision in patients with hypertension, kidney disease, heart disease, arrhythmia risk, pregnancy, or complex medication schedules.

Netra Tarpana for AMD Support

Netra Tarpana is a classical Netra Kriyakalpa in which warm ghrita or medicated ghrita is retained over the closed or blinking eyes within a dough boundary for a prescribed duration. In practice, preparations such as plain cow ghee, Triphala Ghrita, or other physician-selected ghritas may be used depending on the condition, season, strength of the patient, and ocular findings.

For AMD, Netra Tarpana should be understood as a supervised supportive therapy rather than a retinal drug delivery substitute. Its classical rationale is Snehana, Brimhana, Chakshushya action, and relief of ocular dryness or strain. Institutional Ayurvedic clinical-research listings include Triphala Ghrita and Anu Taila protocols for dry AMD or Jarajanya Drishtigata Roga, and separate clinical literature has evaluated Tarpana-like ghrita therapies in dry eye. In an AMD patient, Tarpana belongs only within coordinated care that includes regular ophthalmology review, OCT or fundus monitoring where advised, and prompt treatment of wet AMD symptoms.

Evidence Summary Table

The following table separates human AMD evidence from classical use and pre-clinical rationale so that each intervention is placed in its proper clinical context.

For related eye health content, our guide to Ayurvedic under-eye care and Netra vitality covers complementary eye support. The antioxidant and rejuvenation principles relevant to long-term ocular tissue care are also discussed in our Rasayana therapy and longevity research review.

References and Further Reading

The references below support the conventional AMD background, the classical Ayurvedic framing, and the botanical or procedural claims retained in this article.

• Wong WL et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040.
• International Agency for the Prevention of Blindness: AMD overview and global blindness context.
• National Eye Institute: AREDS/AREDS2 and wet AMD treatment guidance.
• American Academy of Ophthalmology: geographic atrophy treatment overview.
• Ayurvedic Pharmacopoeia of India: Kumkuma and Yashti monographs.
• Sushruta Samhita and Ashtanga Hridaya ophthalmology sections on Drishti and Timira.
• Falsini et al., Piccardi et al., Lashay et al., and Broadhead et al. on saffron supplementation in AMD.
• Retinal endothelial and ocular angiogenesis literature on Triphala-derived compounds and isoliquiritigenin.
• Clinical and classical literature on Netra Tarpana and Triphala Ghrita in eye care.

Safety and Clinical Use

Age-related macular degeneration is a serious ophthalmic condition requiring regular monitoring by an ophthalmologist, including retinal examination and OCT imaging when advised. The herbs and therapies described here are adjunctive supports, not replacements for AREDS2 guidance, anti-VEGF injections for wet AMD, complement-inhibitor therapy for geographic atrophy, or any other treatment recommended by an eye specialist. Sudden distortion, central dark spots, new blurring, flashes, floaters, or rapid vision change require urgent eye evaluation. Consult a qualified Ayurvedic practitioner, ophthalmologist, and healthcare provider before starting saffron, Triphala, Yashtimadhu, Netra Tarpana, supplements, or therapeutic protocols, especially if pregnant, elderly, hypertensive, diabetic, medically fragile, or taking prescription medication.

References

1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis (2014), PubMed
2. Iapb (iapb.org)
3. Nei (nei.nih.gov)
4. Nei (nei.nih.gov)
5. Aao (aao.org)
6. LWW Journals
7. En (en.wikisource.org)
8. Easyayurveda (easyayurveda.com)
9. Ayurvedic Pharmacopoeia of India
10. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration (2010), PubMed
11. A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function (2012), PubMed
12. Short-term Outcomes of Saffron Supplementation in Patients with Age-related Macular Degeneration: A Double-blind, Placebo-controlled, Randomized Trial (2016), PubMed
13. Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial (2019), PubMed
14. Saffron therapy for the ongoing treatment of age-related macular degeneration (2024), PubMed
15. Drugs (drugs.com)
16. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
17. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation (2018), PubMed
18. Journals (journals.plos.org)
19. Efficacy of Triphala Ghrita and Goghrita Manda Tarpana in the management of Shushkakshipaka w.s.r. to dry eye syndrome: An open labelled randomized comparative clinical trial (2020), PubMed Central
20. Ayurvedic Pharmacopoeia of India
21. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models (2011), PubMed
22. NCCIH
23. Ayushdhara (ayushdhara.in)
24. CCRAS
25. Naripcheruthuruthy (naripcheruthuruthy.ccras.res.in)